Open-access Longitudinal study of hearing preservation and electrocochleography after cochlear implantation in adults

Abstract

Objectives:  Electrocochleography (ECOG) is a composite objective measure of the cochlea and the cochlear nerve responses. The objectives of this study were to investigate the evolution of ECOG after cochlear implantation and compare them with audiometric thresholds over a 12-month period.

Methods:  A prospective monocentric study was conducted in Advanced Bionics cochlear implant recipients. Audiometric thresholds were recorded preoperatively and at 1-, 3-, 6-, and 12-months post cochlear implantation; ECOGs were recorded perioperatively after the electrode array insertion and at 1-, 3-, 6-, and 12-months post cochlear implantation. Cochlear Microphonic (CM) responses were measured by an apical electrode of the cochlear implant. Postoperative behavioral and ECOG thresholds were compared using Pearson correlation analyses.

Results:  A total of 17 patients were included. At 1-year, residual hearing (≤90 dB HL at 500 Hz) was preserved for 4 out of 17 patients. Significant correlations were observed between perioperative ECOG and preoperative audiometric thresholds (p = 0.008), and between ECOG and audiometric thresholds at 3-months postoperative (p = 0.002).

Conclusion:  ECOG can reflect changes in cochlear responses during and after implantation and may help to predict deterioration of residual hearing. Level of evidence: Level 3.

Keywords
Electrocochleography; ECOG; Residual hearing; Cochlear implant; Hearing preservation

Introduction

Cochlear implantation can be indicated for patients with residual hearing in low frequencies.1 Residual hearing in implanted patients is beneficial, since it contributes to a higher quality of sound, better speech perception in noise,2, 3, 4 and greater music recognition.5, 6 However, the literature shows that residual hearing tends to deteriorate with time in implanted patients. A systematic review by Talbot and Hartley7 showed that out of 253 implanted patients with residual hearing, 13% lost their residual hearing completely, and 24% had a loss of >20 dB.

Previous studies have identified factors associated with deterioration of residual hearing after cochlear implantation. Intrinsic patient factors such as age, sex and etiology of deafness may impact the evolution of post-implantation residual hearing.8 Early residual hearing loss has been noted due to surgical trauma.9 Changes in electrode size,10, 11 flexibility12 and surgical insertion technique13, 14, 15, 16 have reduced the risk of intraoperative trauma. Finally, there are later impairments to residual hearing due to excitotoxicity17, 18 and the immune response to the foreign body in the cochlea.19, 20

Subjective audiometry is the reference test for post-implantation follow-up for acoustic hearing preservation. However, audiometry has limitations, particularly for children, in whom it can be difficult to reliably measure behavioral thresholds. Moreover, the audiogram alone may not be a sufficient measure of deterioration or loss of residual hearing because it cannot determine the origin of the lesion (cochlear or nerve damage).

Electrocochleography (ECOG) is a composite objective measure of the cochlea and the cochlear nerve responses. The response is recorded in the form of several potentials: the pre-synaptic Cochlear Microphonic (CM) corresponds to the Outer Hair Cell (OHC) micromechanical movements; the Summation Potential (SP) represents both the OHC and Inner Hair Cell (IHC) responses; the Compound Action Potential (CAP) and the Auditory Nerve Neurophonic (ANN) are post-synaptic potentials that represent the cochlear nerve response.21

There are few studies to date that compare post-implantation ECOG and audiometric thresholds over the long term.22, 23 The aims of this study were to investigate the evolution of ECOGs after cochlear implantation, and to compare ECOG with audiometric thresholds over a 12-month period. We hypothesized that ECOG would be predictive of postoperative audiometric thresholds in the short and long term, and thus would be a worthwhile objective measure of residual hearing over time.

Methods

This was a prospective monocentric study in a French tertiary university hospital. We included patients who were candidates for cochlear implantation with the Advanced Bionics device between May 2021 and August 2022 who had residual hearing better than or equal to 90 dB at 500 Hz. Patients with auditory neuropathy and/or cochlear anatomical abnormalities were excluded. A total of 19 patients were enrolled in the study; two patients were later excluded due to insufficient data. Table 1 shows demographic information for the 17 patients who completed the study. This study was approved by the French data protection authority (Commission Nationale de l’Informatique et des Libertes; n°2021_061) and each patients signed a written consent.

Table 1
Patient characteristics.

For each patient, a CT scan of the temporal bone, an MRI of the internal ear, and pure-tone audiometry were performed as part of the preoperative work-up. Fig. 1 shows preoperative audiometric thresholds for all participants. ECOGs were collected during surgery, after the electrode array insertion. In the postoperative period, a CT scan of the temporal bone confirmed the position of the electrode. At 1-, 3-, 6-, and 12-months after surgery, ECOGs and audiometric thresholds at 500 Hz were measured again, within the limits of patient’s availability.

Fig. 1
Preoperative behavioural thresholds. Each line represents the audio-metric threshold of one patient. The bold line represents the mean threshold across the 17 patients.

ECOG measurement technique

An ER-3A insert (Etymotic Research, Inc. 61 Martin Lane, Elk Grove Village, IL) and an ER-7 microphone (Etymotic Research, Inc. 61 Martin Lane, Elk Grove Village, IL) were placed in the ear canal of the implanted ear. The implant electrodes and the Naida CI Q90 sound processor were used to measure ECOGs using the manufacturer’s equipment (Advanced Bionics’ Active Insertion Monitoring system). Pure-tone acoustic stimuli at 500-, 1000-, 2000-, and 4000-Hz, 115 dB SPL, and 50 ms in duration were used to measure ECOG responses. For each subject the most apical electrode was used as the recording electrode. However, ECOG responses were unreliable at 1000-, 2000-, and 4000-Hz, most likely due to the limited acoustic hearing in the present participants. As such, ECOG responses are reported only for 500 Hz, consistent with Tejani et al.23 The CM response was compared to the noise floor; the response was considered significant if it was 3 times above the noise floor.

Statistical analysis

All statistical analyses were performed using SPSS software (version 20; Armonk, NY). Characteristics of the participants, audiometric thresholds and ECOG responses after implantation were described according to their nature by sample size and percentages or by mean and standard deviation. A Kaplan-Meier survival analysis was performed on the behavioral 500-Hz threshold data, with threshold > 90 dB HL as the outcome.

Linear Mixed Model (LMM) analysis was performed on the behavioral threshold and ECOG data, with time (preoperative, 1-month postoperative, 3-months postoperative, 6-months postoperative, 12-months postoperative) as the fixed factor and participant as the random factor; age and duration of hearing loss were co-variables. Because age at test and age at CI were strongly correlated (r = 0.99, p < 0.001), these variables were collapsed into a single factor (“age”) for subsequent analysis using Principal Components Analysis (PCA).

Preoperative behavioral thresholds at 500 Hz were compared to postoperative thresholds at 1-, 3-, 6-, and 12-months. Perioperative ECOGs at 500-Hz were compared to postoperative ECOGs at 1-, 3-, 6-, and 12-months. Postoperative behavioral and ECOG thresholds were compared at 1-, 3-, 6-, and 12-months postoperative. Pearson correlations were used for all comparisons.

For all statistical tests, significance was p < 0.05.

Results

Audiometric thresholds evolution

All patients had audiometric thresholds <90 dB HL at 500-Hz prior to surgery. Mean thresholds at 500-Hz were 74 ± 13 dB HL preoperatively, 101 ± 15 dB HL, 100 ± 16 dB HL, 102 ± 15 dB HL, and 107 ± 16 dB HL, at 1-, 3-, 6-, and 12-months postoperatively, respectively. Residual hearing tended to decline, especially during the first month after cochlear implantation. Fig. 2 shows the results of the Kaplan-Meier survival analysis; the percentage of patients where the audiometric threshold at 500-Hz were ≤90 dB HL is shown as a function of time. After 12-months, only 4 out of 17 patients had residual hearing ≤ 90 dB HL at 500-Hz.

Fig. 2
Percentage of patients with residual acoustic hearing ≤90 dB HL as a function of time. Time 0, Preoperative thresholds. Time >1, Postoperative thresholds.

LMM analysis was performed on the behavioral threshold data, with time (preoperative, 1-, 3-, 6-, and 12-months postoperative) as the fixed factor, participant as the random factor, and age and duration of hearing loss as co-variables. Results showed significant effects for time [F (4,40.3) = 5.1, p = 0.002] and age [F(1,11.8) = 6.3, p = 0.027], but not for duration of hearing loss [F(1,11.8) = 2.6, p = 0.134]; there were no significant interactions among time, age, and duration of hearing loss. Post-hoc Bonferroni comparisons showed that preoperative thresholds were significantly lower (better) than at 1-, 3-, 6-, or 12-months postoperative, and significantly lower at 6-months postoperative than at 12-months postoperative (p < 0.05 in all cases).

Fig. 3 shows behavioral thresholds at 500-Hz at 1-, 3-, 6-, and 12-months postoperative as a function of preoperative thresholds. Values above the solid diagonal line indicate that postoperative thresholds are higher than preoperative thresholds. The dashed line shows the linear regression through the data. Note that behavioral data was not available for all participants at all time points. Significant correlations were observed at all time points, suggesting that preoperative thresholds were a good predictor of postoperative thresholds. Preoperative thresholds were ≤90 dB HL for all participants. At 12-months postoperative, thresholds for all but 4 participants were >90 dB HL.

Fig. 3
Postoperative 500-Hz behavioral thresholds at 1-, 3-, 6-, and 12-months as a function of preoperative thresholds. The different symbols and colors represent individual patient data and are consistent across panels. The solid diagonal line represents unity; values above the line indicate higher (poorer) postoperative thresholds relative to preoperative thresholds. The dashed line shows the regression through the data; r and p-values are shown at the bottom right of each panel. Note that data were not available for all patients at all time points; hence there is missing data for some patients in some panels.

ECOG evolution

Mean ECOG thresholds at 500-Hz were 95 ± 17 dB during surgery (after cochlear implant insertion in the round window), 97 ± 13, 95 ± 14, 102 ± 10, and 101 ± 14 dB, at 1-, 3-, 6-, and 12-months post-operatively, respectively. LMM analysis was also performed on the ECOG threshold data, with time as the fixed factor, participant as the random factor, and age and duration of hearing loss as co-variables. Results showed no significant effects for time [F(4,38) = 1.0, p = 0.410], age [F(1,14.3) = 3.1, p = 0.099], or duration of hearing loss [F (1,12.5) = 1.8, p = 0.204]; a significant interaction was observed only between age and duration of hearing loss [F(1,14.2) = 5.6, p = 0.033].

Similar to Fig. 3, Fig. 4 shows postoperative ECOG thresholds at 500-Hz at 1-, 3-, 6-, and 12-months as a function of perioperative thresholds (after the electrode array insertion). Significant correlations were observed at 3-, 6-, and 12-months postoperative, but not at 1-month postoperative. Perioperative thresholds were ≤90 dB HL for only 5 participants. At 12-months postoperative, thresholds for all but 3 participants were >90 dB HL. If the threshold cut-off is changed to 100 dB HL, perioperative thresholds were ≤100 dB HL for 10 participants; at 12-months postoperative, thresholds for all but 4 participants were >100 dB HL.

Fig. 4
Postoperative ECOG thresholds at 1-, 3-, 6-, and 12-months as a function of peri-operative thresholds. The different symbols and colors represent individual patient data and are consistent across panels. The solid diagonal line represents unity; values above the line indicate higher (poorer) postoperative thresholds relative to peri-operative thresholds. The dashed line shows the regression through the data; r and p-values are shown at the bottom right of each panel. Note that data were not available for all patients at all time points; hence there is missing data for some patients in some panels.

Relationship between ECOG and audiometric thresholds

Fig. 5 shows 500-Hz ECOG thresholds as a function of 500-Hz behavioral thresholds before surgery, during surgery (after the electrode array insertion), and at 1-, 3-, 6-, and 12-months postoperative. Significant correlations were observed only between perioperative ECOG and preoperative behavioral thresholds (p = 0.008), and between ECOG and behavioral thresholds at 3-months postoperative (p = 0.002). By 12-months postoperative, there was no relation whatsoever between ECOG and behavioral thresholds.

Fig. 5
ECOG thresholds as a function of behavioral thresholds. Data are shown for perioperative ECOGs vs. preoperative behavioral thresholds, and for ECOG vs. behavioral thresholds at 1-, 3-, 6-, and 12-months postoperative. The different symbols and colors represent individual patient data and are consistent across panels. The solid diagonal line represents unity; values above the line indicate higher (poorer) ECOG thresholds compared to behavioral thresholds. The dashed line shows the regression through the data; r and p-values are shown at the bottom right of each panel. Note that data were not available for all patients at all time points; hence there is missing data for some patients in some panels.

Discussion

Residual hearing

In this study, audiometric thresholds significantly increased during the first year after cochlear implantation, with most patients (13/17) completely losing their residual hearing. As shown in Fig. 3, better thresholds before surgery were strongly predictive of thresholds after surgery. Previous studies have demonstrated significant preservation of residual hearing after cochlear implant surgery.2, 6, 7, 24, 25, 26, 27, 28 In those studies, inclusion criteria were 500-Hz thresholds ≤65 dB HL. In the present study, patients had less acoustic hearing before implantation, with a mean preoperative 500-Hz threshold of 73 dB HL, with 90 dB HL thresholds for 5/17 patients. Previous studies had shorter follow-ups of 1- and 3-months,6, 25, 26, 27 versus the 1- to 12-month follow-up in the present study.

Preserving post-implantation residual hearing over the long term remains a challenge. There are different approaches to preserve residual hearing. Surgical trauma to the cochlea can be reduced by using new technologies, such as robotics-assisted cochlear implantation.16, 29 Electrode array insertions performed by robotics-assisted system showed significantly lower insertion forces and less variability than observed with manual insertions. Decreasing the auto-immune response against the foreign body either by dexamethasone20, 30 or by a protective film on the electrode array31, 32 may help to preserve residual hearing. Dexamethasone diffusion in the inner ear via drug-eluting electrodes may reduce the local inflammatory response by reducing the macrophages’ action and thereby minimizing cochlear fibrosis. Biomaterial coatings of the electrode array may limit friction and forces during electrode insertion, thereby reducing inflammation and secondary fibrosis in the cochlea. ECOGs can be used for intraoperative monitoring of electrode insertion depth through the round window. Previous studies have shown that ECOG amplitudes during insertion are predictive of postoperative residual hearing preservation.33, 34, 35, 36 However, it is still unclear how ECOGs may be used to guide electrode insertion to better preserve residual hearing.

When hearing preservation is possible, “hybrid” CI signal processors can provide both low-frequency acoustic stimulation via hearing aid and higher-frequency electric stimulation via CI (combined “Electro-Acoustic Stimulation”, or EAS). In general, EAS patients have a maximum hearing loss of 65 dB between 125 and 750 Hz.11 The benefit of EAS relies on preservation of residual hearing over the long term.

ECOG

Previous studies have reported significant associations between behavioral and postoperative ECOG thresholds.22, 37, 38, 39, 40, 41, 42 Most previous studies compared ECOG and audiometric thresholds at only one or two postoperative test points;37, 38, 41, 42, 43 there are few studies with long-term monitoring of ECOG evolution.22, 23 In the present study, follow-up measures were conducted out to 12-months postoperative. ECOG measures during surgery and preoperative behavioral thresholds at 500 Hz were significantly correlated as well as at 3-months postoperative; no correlations were observed at later follow-ups.

Conclusion

In the present study, while low-frequency residual hearing could sometimes be preserved at 1- or 3-months post-implantation, most patients (13/17) lost their residual hearing by 12-months post-implantation. The correlations observed between 500 Hz ECOG and behavioral thresholds suggest that ECOG can predict changes in cochlear responses during and after implantation.

  • Funding
    This study was not supported by any funding.

Statements and declarations

This manuscript is not under consideration elsewhere.

Ethical approval: This study was approved by the French data protection authority (CNIL; nº 2021_061) and the local ethics committee in human research (nº 2021_029). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.

Informed consent: Informed consent was obtained from all individual participants included in the study.

Data availability statement: The data that support the findings of this study are available from the corresponding author upon reasonable request

References

  • 1 Hodges AV, Schloffman J, Balkany T. Conservation of residual hearing with cochlear implantation. Am J Otol. 1997;18:179–183.
  • 2 Skarzynski H, Lorens A. Electric acoustic stimulation in children. Adv Oto-Rhino-Laryngol. 2010;67:135–143.
  • 3 Gifford RH, Dorman MF, Skarzynski H, et al. Cochlear implantation with hearing preservation yields significant benefit for speech recognition in complex listening environments. Ear Hear. 2013;34:413–425.
  • 4 Turner CW, Gantz B, Karsten S, Fowler J, Reiss LA. Impact of hair cell preservation in cochlear implantation: combined electric and acoustic hearing. Otol Neurotol. 2010;31:1227–1232.
  • 5 Gfeller KE, Olszewski C, Turner C, Gantz B, Oleson J. Music perception with cochlear implants and residual hearing. Audiol Neurotol. 2006;11:12–15.
  • 6 Gantz B, Turner C, Gfeller KE, Lowder MW. Preservation of hearing in cochlear implant surgery: advantages of combined electrical and acoustical speech processing. Laryngoscope. 2005;115:796–802.
  • 7 Talbot KN, Hartley DEH. Combined electro-acoustic stimulation: a beneficial union? Clin Otolaryngol. 2008;33:536–545.
  • 8 Kopelovich JC, Reiss LAJ, Oleson JJ, Lundt ES, Gantz BJ, Hansen MR. Risk factors for loss of ipsilateral residual hearing after hybrid cochlear implantation. Otol Neurotol. 2014;35:1403–1408.
  • 9 Adunka OF, Pillsbury HC, Buchman CA. Minimizing intracochlear trauma during cochlear implantation. Adv Otorhinol. 2009;67:96–107.
  • 10 Balkany TJ, Connell SS, Hodges AV, et al. Conservation of residual acoustic hearing after cochlear implantation. Otol Neurotol. 2006;27:1083–1088.
  • 11 Von Ilberg CA, Baumann U, Kiefer J, Tillein J, Adunka OF. Electric-acoustic stimulation of the auditory system: a review of the first decade. Audiol Neurotol. 2011;16:1–30.
  • 12 Skarzynski H, Podskarbi-Fayette R. A new cochlear implant electrode design for preservation of residual hearing: a temporal bone study. Acta Otolaryngol. 2010;130:435–442.
  • 13 Briggs RJS, Tykocinski M, Stidham K, Roberson JB. Cochleostomy site: Implications for electrode placement and hearing preservation. Acta Otolaryngol. 2005;125:870–876.
  • 14 Briggs RJS, Tykocinski M, Xu J, et al. Comparison of round window and cochleostomy approaches with a prototype hearing preservation electrode. Audiol Neurotol. 2006;11:42–48.
  • 15 Helbig S, Adel Y, Leinung M, Stover T, Baumann U, Weissgerber T. Hearing preservation outcomes after cochlear implantation depending on the angle of insertion: indication for electric or electric-acoustic stimulation. Otol Neurotol. 2018;39:834–841.
  • 16 Kaufmann CR, Henslee AM, Claussen A, Hansen MR. Evaluation of insertion forces and cochlea trauma following robotics-assisted cochlear implant electrode array insertion. Otol Neurotol. 2020;41:631–638.
  • 17 Kopelovich JC, Reiss LAJ, Etler CP, et al. Hearing loss after activation of hearing preservation cochlear implants might be related to afferent cochlear innervation injury. Otol Neurotol. 2015;36:1035–1044.
  • 18 Li C, Kuhlmey M, Kim AH. Electroacoustic stimulation. Otolaryngol Clin North Am 2019;52:311–322.
  • 19 Quesnel AM, Nakajima HH, Rosowski JJ, Hansen MR, Gantz BJ, Nadol JB. Delayed loss of hearing after hearing preservation cochlear implantation: Human temporal bone pathology and implications for etiology. Hear Res. 2016;333:225–234.
  • 20 Foggia MJ, Quevedo RV, Hansen MR. Intracochlear fibrosis and the foreign body response to cochlear implant biomaterials. Laryngoscope Investig Otolaryngol. 2019;4:678–683.
  • 21 Bakhos D, Marx M, Villeneuve A, Lescanne E, Kim S, Robier A. Electrophysiological exploration of hearing. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134:325–331.
  • 22 Abbas PJ, Tejani VD, Scheperle RA, Brown CJ. Using neural response telemetry to monitor physiological responses to acoustic stimulation in hybrid cochlear implant users. Ear Hear. 2017;38:409–425.
  • 23 Tejani VD, Kim JS, Oleson JJ, et al. Residual hair cell responses in electric-acoustic stimulation cochlear implant users with complete loss of acoustic hearing after implantation. J Assoc Res Otolaryngol. 2021;22:161–176.
  • 24 Campbell AP, Dillon MT, Buchman CA, Adunka OF. Hearing preservation cochlear implantation. Curr Otorhinolaryngol. 2013;1:69–79.
  • 25 Gstoettner W, Kiefer J, Baumgartner WD, Pok S, Peters S, Adunka O. Hearing preservation in cochlear implantation for electric acoustic stimulation. Acta Otolaryngol. 2004;124:348–352.
  • 26 James C, Albegger K, Battmer R, et al. Preservation of residual hearing with cochlear implantation: how and why. Acta Otolaryngol. 2005;125:481–491.
  • 27 Kiefer J, Gstoettner W, Baumgartner W, et al. Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol. 2004;124:272–280.
  • 28 Lenarz T, Stover T, Buechner A, Lesinski-Schiedat A, Patrick J, Pesch J. Hearing conservation surgery using the Hybrid-L electrode. Results from the first clinical trial at the Medical University of Hannover. Audiol Neurootol. 2009;1:22–31.
  • 29 Heuninck E, Van de Heyning P, Van Rompaey V, Mertens G, Topsakal V. Audiological outcomes of robot-assisted cochlear implant surgery. Eur Arch Otorhinol. 2023;280:4433–4444.
  • 30 Chen D, Luo Y, Pan J, et al. Long-term release of dexamethasone with a polycaprolactone-coated electrode alleviates fibrosis in cochlear implantation. Front Cell Dev Biol. 2021;9, 740576.
  • 31 Bennion DM, Horne R, Peel A, et al. Zwitterionic photografted coatings of cochlear implant biomaterials reduce friction and insertion forces. Otol Neurotol. 2021;42:1476–1483.
  • 32 Horne R, Ben-Shlomo N, Jensen M, et al. Reducing the foreign body response on human cochlear implants and their materials in vivo with photografted zwitterionic hydrogel coatings. Acta Biomater. 2023;166:212–223.
  • 33 Weder S, Bester C, Collins A, Shaul C, Briggs RJ, O’Leary S. Toward a better understanding of electrocochleography: analysis of real-time recordings. Ear Hear. 2020;41:1560–1567.
  • 34 O’Leary S, Briggs R, Gerard JM, et al. Intraoperative observational real-time electrocochleography as a predictor of hearing loss after cochlear implantation: 3-and 12-month outcomes. Otol Neurotol. 2020;41:1222–1229.
  • 35 Giardina CK, Khan TE, Pulver SH, et al. Response changes during insertion of a cochlear implant using extracochlear electrocochleography. Ear Hear. 2018;39:1146–1156.
  • 36 Dalbert A, Pfiffner F, Hoesli M, et al. Assessment of cochlear function during cochlear implantation by extra- and intracochlear electrocochleography. Front Neurosci. 2018;12:18.
  • 37 Attias J, Ulanovski D, Hilly O, et al. Postoperative intracochlear electrocochleography in pediatric cochlear implant recipients: association to audiometric thresholds and auditory performance. Ear Hear. 2020;41:1135–1143.
  • 38 Coulthurst S, Nachman AJ, Murray MT, Koka K, Saoji AA. Comparison of pure-tone thresholds and cochlear microphonics thresholds in pediatric cochlear implant patients. Ear Hear. 2020;41:1320–1326.
  • 39 Haumann S, Imsiecke M, Bauernfeind G, et al. Monitoring of the inner ear function during and after cochlear implant insertion using electrocochleography. Trends Hear. 2019;23, 2331216519833567.
  • 40 Kim JS, Tejani VD, Abbas PJ, Brown CJ. Postoperative electrocochleography from hybrid cochlear implant users: an alternative analysis procedure. Hear Res. 2018;370:304–315.
  • 41 O’Connell BP, Holder JT, Dwyer RT, et al. Intra- and postoperative electrocochleography may be predictive of final electrode position and postoperative hearing preservation. FrontNeurosci. 2017;11:291.
  • 42 Koka K, Saoji AA, Litvak LM. Electrocochleography in cochlear implant recipients with residual hearing: comparison with audiometric thresholds. Ear Hear. 2017;38:7.
  • 43 Kim JR, Tejani VD, Abbas PJ, Brown CJ. Intracochlear recordings of acoustically and electrically evoked potentials in nucleus hybrid L24 cochlear implant users and their relationship to speech perception. Front Neurosci. 2017;11:216.

Publication Dates

  • Publication in this collection
    19 Sept 2025
  • Date of issue
    2025

History

  • Received
    28 Oct 2024
  • Accepted
    19 Feb 2025
  • Published
    26 Mar 2025
location_on
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Sede da Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico Facial, Av. Indianópolia, 1287, 04063-002 São Paulo/SP Brasil, Tel.: (0xx11) 5053-7500, Fax: (0xx11) 5053-7512 - São Paulo - SP - Brazil
E-mail: revista@aborlccf.org.br
rss_feed Acompanhe os números deste periódico no seu leitor de RSS
Ir para o topo Reportar erro